Which are the symptoms of IgA nephropathy?

TL;DR: IgA nephropathy is a chronic autoimmune kidney disease often characterized by hematuria (blood in the urine) and proteinuria (excess protein in the urine). While many patients remain asymptomatic for years, others experience progressive kidney function decline, requiring long-term monitoring by a nephrologist to manage blood pressure and potential renal complications.

What are the primary symptoms of IgA nephropathy?

The clinical presentation of IgA nephropathy is highly variable, ranging from silent, microscopic findings to acute symptomatic episodes. The most hallmark sign is hematuria, which can be microscopic (detectable only via laboratory tests) or macroscopic (visible to the naked eye, often following a respiratory or gastrointestinal infection). Many individuals with IgA nephropathy also present with proteinuria, where the kidneys leak protein into the urine. Because these symptoms often lack physical pain, the disease is frequently discovered during routine medical screenings rather than through patient-reported physical discomfort.

What are the early warning signs to monitor?

Because IgA nephropathy often progresses silently, early detection relies on recognizing subtle changes in urine and blood pressure. Patients and families should watch for the following clinical indicators:

• Visible Hematuria: Urine that appears tea-colored, cola-colored, or pink, especially following a cold or flu.


• Foamy Urine: A persistent, bubbly appearance in the toilet bowl, which may indicate significant proteinuria.


• Hypertension: High blood pressure, which is both a common symptom and a driver of further kidney damage.


• Edema: Unexplained swelling, particularly in the lower legs, ankles, or around the eyes, suggesting the kidneys are struggling to manage fluid balance.


• Fatigue: A general feeling of malaise or tiredness that may result from mild anemia or the body’s systemic inflammatory response.

How does IgA nephropathy affect quality of life?

For the 347 members of the DiseaseMaps community living with IgA nephropathy, quality of life is often impacted by the "invisible" nature of the condition. Chronic fatigue, the psychological burden of frequent medical appointments, and the anxiety surrounding potential progression to end-stage renal disease (ESRD) are common concerns. In more advanced cases, individuals may experience significant physical limitations due to fluid retention and the side effects of medications, such as immunosuppressants or blood pressure-lowering drugs like ACE inhibitors, which are standard of care for IgA nephropathy.

When should I seek immediate medical attention?

While IgA nephropathy is typically a slow-progressing condition, certain symptoms warrant urgent evaluation by a medical professional. You should seek immediate care if you experience:

1. A sudden, dramatic decrease in urine output or complete cessation of urination.


2. Severe, unexplained swelling or rapid weight gain over a few days.


3. Chest pain or shortness of breath, which may indicate fluid overload impacting the heart or lungs.


4. Confusion, severe nausea, or persistent vomiting, which can be signs of uremia (a buildup of waste products in the blood).

How do symptoms evolve over time?

The progression of IgA nephropathy is unpredictable. Approximately 20% to 40% of patients may eventually progress to end-stage renal disease over 20 years. Over time, as the glomeruli (the kidney's filtering units) become increasingly scarred (glomerulosclerosis), the kidneys lose their ability to filter blood effectively. This transition often shifts the symptom profile from episodic hematuria to constant proteinuria, rising serum creatinine levels, and symptomatic chronic kidney disease (CKD).

Next steps

• Consult a board-certified nephrologist to establish a baseline for your kidney function, including eGFR and albumin-to-creatinine ratio (ACR) tests.


• Join the DiseaseMaps community to connect with other patients who understand the daily challenges of managing IgA nephropathy.


• Maintain a strict log of your blood pressure readings and any observed changes in urine color or volume to share with your care team.


• Ask your doctor about current clinical trials if your condition is not well-managed by standard therapies.

Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH GARD (Genetic and Rare Diseases Information Center): IgA Nephropathy Overview.


• Orphanet: Clinical practice guidelines for the management of IgA nephropathy.


• OMIM (Online Mendelian Inheritance in Man): Genetic factors in IgA nephropathy (#161950).


• Kidney Disease: Improving Global Outcomes (KDIGO): Clinical Practice Guideline for the Management of Glomerular Diseases.